Clinical Trial Update: RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for remimazolam besylate used for ICU sedation in mechanically ventilated patients after oral and maxillofacial surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Sedation-related Indications

Drugs mentioned

• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Remimazolam Besylate, Sedation | Phase 4 | Status: UNKNOWN